Central Florida Internal Med is categorized under Internal Medicine Doctors in Bartow, FL and active since 2007.
Central Florida Internal Med was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Isabella A Korley at the company’s single location by writing to 2000 Osprey Boulevard # 100, Bartow, Florida FL 33830 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Internal Med |
| Contact Person: | Isabella A Korley |
| Address: | 2000 Osprey Boulevard # 100, Bartow, Florida 33830 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Central Florida Internal Med was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Isabella A Korley for inquiries that concern Central Florida Internal Med by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Internal Med can be found at the coordinates 27.917363,-81.84389 as well as the street address 2000 Osprey Boulevard # 100 in Bartow, Florida 33830.
For its online presence, you may visit Central Florida Internal Med’s website at and engage with its social media outlets through on Twitter and on Facebook.